Search Results - "Akahane, Toshiaki"

Refine Results
  1. 1
  2. 2

    Genome Editing Using Cas9 Ribonucleoprotein Is Effective for Introducing PDGFRA Variant in Cultured Human Glioblastoma Cell Lines by Hamada, Taiji, Yokoyama, Seiya, Akahane, Toshiaki, Matsuo, Kei, Tanimoto, Akihide

    “…Many variants of uncertain significance (VUS) have been detected in clinical cancer cases using next-generation sequencing-based cancer gene panel analysis…”
    Get full text
    Journal Article
  3. 3

    An oncogenic splice variant of PDGFRα in adult glioblastoma as a therapeutic target for selective CDK4/6 inhibitors by Hamada, Taiji, Akahane, Toshiaki, Yokoyama, Seiya, Higa, Nayuta, Kirishima, Mari, Matsuo, Kei, Shimokawa, Michiko, Yoshimoto, Koji, Tanimoto, Akihide

    Published in Scientific reports (24-01-2022)
    “…Understanding human genome alterations is necessary to optimize genome-based cancer therapeutics. However, some newly discovered mutations remain as variants…”
    Get full text
    Journal Article
  4. 4

    Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene Panel by HIGA, Nayuta, AKAHANE, Toshiaki, YOKOYAMA, Seiya, YONEZAWA, Hajime, UCHIDA, Hiroyuki, FUJIO, Shingo, KIRISHIMA, Mari, TAKIGAWA, Kosuke, HATA, Nobuhiro, TOH, Keita, YAMAMOTO, Junkoh, HANAYA, Ryosuke, TANIMOTO, Akihide, YOSHIMOTO, Koji

    Published in Neurologia Medico-Chirurgica (15-09-2022)
    “…Rapid technological advances in molecular biology, including next-generation sequencing, have identified key genetic alterations in central nervous system…”
    Get full text
    Journal Article
  5. 5

    PCP4/PEP19 downregulates neurite outgrowth via transcriptional regulation of Ascl1 and NeuroD1 expression in human neuroblastoma M17 cells by Kitazono, Ikumi, Hamada, Taiji, Yoshimura, Takuya, Kirishima, Mari, Yokoyama, Seiya, Akahane, Toshiaki, Tanimoto, Akihide

    Published in Laboratory investigation (01-12-2020)
    “…Purkinje cell protein 4/peptide 19 (PCP4/PEP19) is 7.6 kDa peptide originally found in Purkinje cells. PCP4/PEP19 is a differentiation maker of Purkinje cells,…”
    Get full text
    Journal Article
  6. 6

    Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesions by Akahane, Toshiaki, Kanomata, Naoki, Harada, Oi, Yamashita, Tetsumasa, Kurebayashi, Junichi, Tanimoto, Akihide, Moriya, Takuya

    Published in BMC cancer (01-10-2020)
    “…Next-generation sequencing (NGS) has shown that recurrent/metastatic breast cancer lesions may have additional genetic changes compared with the primary tumor…”
    Get full text
    Journal Article
  7. 7

    MALAT1 functions as a transcriptional promoter of MALAT1::GLI1 fusion for truncated GLI1 protein expression in cancer by Hamada, Taiji, Higashi, Michiyo, Yokoyama, Seiya, Akahane, Toshiaki, Hisaoka, Masanori, Noguchi, Hirotsugu, Furukawa, Tatsuhiko, Tanimoto, Akihide

    Published in BMC cancer (10-05-2023)
    “…The long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a cancer biomarker. Furthermore, fusion of the MALAT1 gene with…”
    Get full text
    Journal Article
  8. 8

    Comprehensive validation of liquid-based cytology specimens for next-generation sequencing in cancer genome analysis by Akahane, Toshiaki, Yamaguchi, Tomomi, Kato, Yasutaka, Yokoyama, Seiya, Hamada, Taiji, Nishida, Yukari, Higashi, Michiyo, Nishihara, Hiroshi, Suzuki, Shinsuke, Ueno, Shinichi, Tanimoto, Akihide

    Published in PloS one (14-06-2019)
    “…In addition to conventional cytology, liquid-based cytology (LBC) is also used for immunocytochemistry and gene analysis. However, an appropriate method to…”
    Get full text
    Journal Article
  9. 9

    Prognosis prediction via histological evaluation of cellular heterogeneity in glioblastoma by Kirishima, Mari, Yokoyama, Seiya, Akahane, Toshiaki, Higa, Nayuta, Uchida, Hiroyuki, Yonezawa, Hajime, Matsuo, Kei, Yamamoto, Junkoh, Yoshimoto, Koji, Hanaya, Ryosuke, Tanimoto, Akihide

    Published in Scientific reports (23-10-2024)
    “…Glioblastomas (GBMs) are the most aggressive types of central nervous system tumors. Although certain genomic alterations have been identified as prognostic…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Direct next‐generation sequencing analysis using endometrial liquid‐based cytology specimens for rapid cancer genomic profiling by Akahane, Toshiaki, Kitazono, Ikumi, Kobayashi, Yusuke, Nishida‐Kirita, Yukari, Yamaguchi, Tomomi, Yanazume, Shintaro, Tabata, Kazuhiro, Kobayashi, Hiroaki, Tanimoto, Akihide

    Published in Diagnostic cytopathology (01-09-2021)
    “…Background Genomic examination of cytology specimens is often performed on cell blocks or conventional smears rather than on liquid‐based cytology (LBC)…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Next‐generation sequencing in residual liquid‐based cytology specimens for cancer genome analysis by Yamaguchi, Tomomi, Akahane, Toshiaki, Harada, Ohi, Kato, Yasutaka, Aimono, Eriko, Takei, Hidehiro, Tasaki, Takashi, Noguchi, Hirotsugu, Nishihara, Hiroshi, Kamata, Hajime, Tanimoto, Akihide

    Published in Diagnostic cytopathology (01-11-2020)
    “…Background Cancer genome profiling of cytology specimens using next‐generation sequencing (NGS) requires adequate and good‐quality DNA. Genomic examination of…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Two Components of Variant Profiles in Primary Vaginal Carcinosarcoma via Next-Generation Sequencing and a Literature Review by Kotoku, Rakan, Yanazume, Shintaro, Kuroda, Takafumi, Kobayashi, Yusuke, Kitazono, Ikumi, Akahane, Toshiaki, Tanimoto, Akihide, Kobayashi, Hiroaki

    “…Primary vaginal carcinosarcoma (VCS) is an extremely rare and aggressive tumor consisting of admixed malignant epithelial and mesenchymal elements. We report a…”
    Get full text
    Journal Article